Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Future Science OA|January 25, 2017
Looking to a future of improved diabetes management: interview with Professor Steve BainSteve BainExpert Opinion on Drug Safety|April 8, 2017
Cardiovascular safety of liraglutide for the treatment of type 2 diabetesR A Chudleigh, Steve BainDiabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 9, 2013
Evaluation of insulin use and value for money in type 2 diabetes in the United kingdomJason Gordon, Marc Evans, Phil McEwan, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 21, 2025
Real-World Comparisons Between Glucagon-Like Peptide-1 Receptor Agonists and Other Glucose-Lowering Agents in Type 2 Diabetes: Retrospective Analyses of Cardiovascular and Economic Outcomes in EnglandDerek Connolly, Edward Collins, Hongye Ren, et al.Journal of Diabetes Science and Technology|January 17, 2019
A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 DiabetesMelanie Davies, Steve Bain, Guillaume Charpentier, et al.Diabetes Research and Clinical Practice|April 11, 2025
Impact of diabetes on long-term mortality following major lower limb amputation: A population-based cohort study in WalesJennifer Hayes, James M Rafferty, Wai-Yee Cheung, et al.Kidney International Reports|April 18, 2023
Narrative Review of Glycemic Management in People With Diabetes on Peritoneal DialysisPiyumi Wijewickrama, Jennifer Williams, Steve Bain, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 25, 2018
SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical PracticeJohn Wilding, Kevin Fernando, Nicola Milne, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 11, 2019
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 20, 2019
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.Pageof 2